Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
Most prostate cancers (PCas) are classified as acinar type (conventional) adenocarcinoma which are composed of tumor cells with luminal differentiation including the expression of androgen receptor (AR) and prostate-specific antigen (PSA). There are also scattered neuroendocrine (NE) cells in every...
Main Authors: | Julia Lipianskaya, Alexa Cohen, Clark J Chen, Elaine Hsia, Jill Squires, Zhen Li, Yaqun Zhang, Wei Li, Xufeng Chen, Hua Xu, Jiaoti Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-08-01
|
Series: | Asian Journal of Andrology |
Subjects: | |
Online Access: | http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=4;spage=541;epage=544;aulast=Lipianskaya |
Similar Items
-
Neuroendocrine and Aggressive-Variant Prostate Cancer
by: Nicholas Spetsieris, et al.
Published: (2020-12-01) -
Neuroendocrine differentiation in prostate cancer – a review
by: R. Popescu, et al.
Published: (2015-12-01) -
Neuroendocrine aspects of prostate oncogenesis
by: P.V. Glybochko, et al.
Published: (2010-03-01) -
Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report
by: Rittu Hingorani, et al.
Published: (2014-11-01) -
Androgen Deprivation Induces Reprogramming of Prostate Cancer Cells to Stem-Like Cells
by: Belén G. Sánchez, et al.
Published: (2020-06-01)